The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,300.00
Bid: 12,300.00
Ask: 12,302.00
Change: 54.00 (0.44%)
Spread: 2.00 (0.016%)
Open: 12,240.00
High: 12,302.00
Low: 12,240.00
Prev. Close: 12,246.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Too soon to say if Britons can take summer holiday abroad, says UK's Johnson

Mon, 05th Apr 2021 07:49

* Summer holiday abroad? Too early to know, UK says

* UK to have traffic light system for travel

* International travel will not start before May 17

* England's economy to start to reopen from April 12

* Johnson to raise a pint on April 12
(Adds quotes)

By Kate Holton, Alistair Smout and Elizabeth Piper

LONDON, April 5 (Reuters) - British Prime Minister Boris
Johnson said on Monday it was too soon to say whether
international summer holidays can go ahead this year, a remark
suggesting a planned reopening of outbound travel could be
pushed back beyond May 17.

Britons are among Europe's highest spending tourists so the
fortunes of the continent's summer season and the travel
industry, hit hard by restrictions imposed on travel because of
the COVID-19 pandemic, will depend on when tourists can return
to the beaches, cafes and tavernas of southern Europe.

Britain plans to use a traffic-light risk system for
countries once non-essential international travel resumes, but
the government said it was too early to say which countries
could be given the green light that would only require
coronavirus tests before and after travel.

"Taking into account the latest situation with (coronavirus)
variants and the evidence about the efficacy of vaccines against
them, we will confirm in advance whether non-essential
international travel can resume on 17 May, or whether we will
need to wait longer before lifting the outbound travel
restriction," a government review said.

Johnson told a news conference he was hopeful that
non-essential international travel would restart from May 17,
but that he did not want to underestimate the growing number of
COVID-19 cases elsewhere.

"Obviously we are hopeful that we can get going from May
17th, but I do not wish to give hostages to fortune or to
underestimate the difficulties that we are seeing in some of the
destination countries that people might want to go to," he said.

British media suggested countries on the green list,
requiring testing before and after travel, could include
Portugal, Malta, Israel, the United Arab Emirates and the United
States.

Under Johnson's original plan, international travel would
not resume until May 17 at the earliest. Countries on the amber
list would require self-isolation. Those on the red list would
require quarantine.

Airlines such as easyJet, Ryanair and
British Airways, plus holiday groups such as TUI
, hope to avoid a second lost summer but COVID-19
cases have risen in continental Europe.

Johnson said a planned reopening of the economy could take
place next week, with the opening of all shops, gyms,
hairdressers and outdoor hospitality areas in England.

VACCINE PASSPORTS

With the vaccine programme rolling out rapidly across
Britain and infection numbers falling, Johnson said England
could proceed to Stage 2 of his roadmap out of lockdown from
April 12.

"On Monday the 12th, I will be going to the pub myself - and
cautiously but irreversibly raising a pint of beer to my lips,"
Johnson said.

Britain said people should continue to work from home where
they can and minimise domestic travel.

Johnson also confirmed that the government was looking at a
COVID-19 status certification system, or vaccine passport, to
help reopen larger events and to travel.

"I want to stress that there are complicated, ethical, and
practical issues... raised by the idea of COVID status
certification... using vaccination alone," Johnson said.

"You've got to be very careful in how you handle this and
... don't start a system that's discriminatory."

People will not need vaccine certification for pubs,
hairdressers and shops, Johnson said.
(Editing by Guy Faulconbridge and Timothy Heritage)

More News
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.